Research Article
Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment
Figure 5
CVB-D protects against DOX-induced cardiac oxidative damage indicated by (a) lipid peroxidation and (b) protein carbonylation. versus the control group; versus the DOX group, .
(a) |
(b) |